7 November 2013 - Deborah Wilkes
Archived
Endo Health Solutions has agreed to acquire the Canadian prescription and OTC pharmaceutical company Paladin Labs in a deal worth C$1.7 billion (US$1.6 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.